These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 1576046)

  • 21. Comparative study of NMDA and AMPA/kainate receptors involved in cardiovascular inhibition produced by imidazoline-like drugs in anaesthetized rats.
    Wang LG; Zeng J; Yuan WJ; Su DF; Wang WZ
    Exp Physiol; 2007 Sep; 92(5):849-58. PubMed ID: 17573415
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute effects of moxonidine on cardiac autonomic modulation.
    Kaya D; Barutcu I; Esen AM; Celik A; Onrat E
    Pacing Clin Electrophysiol; 2010 Aug; 33(8):929-33. PubMed ID: 20230461
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of moxonidine on stress-induced peak blood pressure and renal function: a randomized, double-blind, placebo-controlled crossover study.
    Fauvel JP; Najem R; Maakel N; Pozet N; Laville M
    J Cardiovasc Pharmacol; 1998 Sep; 32(3):495-9. PubMed ID: 9733365
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Receptors involved in moxonidine-stimulated atrial natriuretic peptide release from isolated normotensive rat hearts.
    Mukaddam-Daher S; Menaouar A; Gutkowska J
    Eur J Pharmacol; 2006 Jul; 541(1-2):73-9. PubMed ID: 16774751
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clonidine, moxonidine, folic acid, and mecobalamin improve baroreflex function in stroke-prone, spontaneously hypertensive rats.
    Ma XJ; Shen FM; Liu AJ; Shi KY; Wu YL; Su DF
    Acta Pharmacol Sin; 2007 Oct; 28(10):1550-8. PubMed ID: 17883939
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preliminary clinical pharmacological studies of S3341, a new hypotensive agent, and comparison with clonidine in normal males.
    Weerasuriya K; Shaw E; Turner P
    Eur J Clin Pharmacol; 1984; 27(3):281-6. PubMed ID: 6150856
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacology and clinical use of moxonidine, a new centrally acting sympatholytic antihypertensive agent.
    Prichard BN; Owens CW; Graham BR
    J Hum Hypertens; 1997 Aug; 11 Suppl 1():S29-45. PubMed ID: 9321737
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence that some imidazoline derivatives inhibit peripherally the vasopressor sympathetic outflow in pithed rats.
    Monroy-Ordoñez EB; Villalón CM; Cobos-Puc LE; Márquez-Conde JA; Sánchez-López A; Centurión D
    Auton Neurosci; 2008 Dec; 143(1-2):40-5. PubMed ID: 18774761
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antagonism of the effects of clonidine by the alpha 2-adrenoceptor antagonist, fluparoxan.
    Johnson MA; Blackwell CP; Smith J
    Br J Clin Pharmacol; 1995 May; 39(5):477-83. PubMed ID: 7669482
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antihypertensive responses elicited by central moxonidine in rats: possible role of nitric oxide.
    Moreira TS; Takakura AC; Sato MA; Menani JV; Colombari E
    J Cardiovasc Pharmacol; 2006 Jun; 47(6):780-7. PubMed ID: 16810079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Central nervous system depressant actions of clonidine and UK-14,304: partial dissociation of EEG and behavioural effects.
    Ashton H; Rawlins MD
    Br J Clin Pharmacol; 1978 Feb; 5(2):135-40. PubMed ID: 619947
    [No Abstract]   [Full Text] [Related]  

  • 32. Preoperative oral dextromethorphan vs. clonidine to prevent tourniquet-induced cardiovascular responses in orthopaedic patients under general anaesthesia.
    Honarmand A; Safavi MR
    Eur J Anaesthesiol; 2007 Jun; 24(6):511-5. PubMed ID: 17202010
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Central nervous system effects of moxonidine experimental sustained release formulation in patients with mild to moderate essential hypertension.
    Kemme MJ; vd Post JP; Schoemaker RC; Straub M; Cohen AF; van Gerven JM
    Br J Clin Pharmacol; 2003 Jun; 55(6):518-25. PubMed ID: 12814444
    [TBL] [Abstract][Full Text] [Related]  

  • 34. GABA mechanisms of the nucleus of the solitary tract regulates the cardiovascular and sympathetic effects of moxonidine.
    Alves TB; Totola LT; Takakura AC; Colombari E; Moreira TS
    Auton Neurosci; 2016 Jan; 194():1-7. PubMed ID: 26633249
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urinary responses to acute moxonidine are inhibited by natriuretic peptide receptor antagonist.
    El-Ayoubi R; Menaouar A; Gutkowska J; Mukaddam-Daher S
    Br J Pharmacol; 2005 May; 145(1):50-6. PubMed ID: 15700025
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A new centrally acting antihypertensive (ICI 106270) which separates antihypertensive effects from sedation.
    Clough DP; Hatton R; Pettinger SJ
    Arzneimittelforschung; 1981; 31(10):1698-703. PubMed ID: 7198445
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison between the effects of ST 600 and clonidine.
    Kho TL; Schalekamp MA; Zaal GA; Wester A; Birkenhäger WH
    Arch Int Pharmacodyn Ther; 1975 Sep; 217(1):162-9. PubMed ID: 1190909
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of structural changes in the imidazolidine ring of clonidine on hypotensive activity.
    Timmermans PB; Van Zwieten PA
    Pharmacology; 1978; 16(2):106-14. PubMed ID: 201948
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The I1-imidazoline agonist moxonidine decreases sympathetic tone under physical and mental stress.
    Wenzel RR; Mitchell A; Siffert W; Bührmann S; Philipp T; Schäfers RF
    Br J Clin Pharmacol; 2004 May; 57(5):545-51. PubMed ID: 15089806
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Moxonidine vs. captopril in minor to intermediate hypertension. Double-blind study of effectiveness and tolerance].
    Lotti G; Gianrossi R
    Fortschr Med; 1993 Sep; 111(27):429-32. PubMed ID: 8225149
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.